Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 40 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ACCELR8 TECHNOLOGY CORP | 8,310,388 | reported | 03 Dec 2024 | tx 240+109,463,187−47,151,793 |
| GTX INC /DE/ | 6,165,261 | reported | 21 Mar 2014 | tx 55+6,328,090−3,006,730 |
| QUIDEL CORP /DE/ | 3,103,249 | reported | 14 May 2020 | tx 291+1,720,094−658,174 |
| Transition Therapeutics Inc. | 2,823,010 | reported | 22 Nov 2011 | tx 1+1,925,926 |
| BIODESIX INC | 1,563,210 | reported | 26 Jan 2026 | tx 70+42,752,230−29,019,839 |
| CIPHERGEN BIOSYSTEMS INC | 833,333 | reported | 17 Sept 2025 | tx 38+31,610,969−2,316,185 |
| BIOLASE TECHNOLOGY INC | 739,820 | reported | 11 Feb 2020 | tx 41+4,368,964−1,307,931 |
| METABOLIX, INC. | 63,789 | reported | 20 Dec 2023 | tx 69+10,961,368−504,738 |
| HANSEN MEDICAL INC | 60,000 | reported | 15 Jun 2015 | tx 5+3,884,094−3,744,094 |
| SOLENO THERAPEUTICS INC | 36,595 | reported | 09 Dec 2022 | tx 118+22,496,861−2,855,929 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 23 Jan 2026 | PURCHASE | BIODESIX INC | 80,000 | 11.81 USD | |
| 26 Jan 2026 | PURCHASE | BIODESIX INC | 20,000 | 11.80 USD | |
| 22 Jan 2026 | PURCHASE | BIODESIX INC | 82,465 | 10.96 USD | |
| 19 Sept 2025 | PURCHASE | BIODESIX INC | 142,045 | 7.04 USD | |
| 17 Sept 2025 | PURCHASE | CIPHERGEN BIOSYSTEMS INC | 1,111,111 | 0.45 USD | |
| 17 Sept 2025 | PURCHASE | CIPHERGEN BIOSYSTEMS INC | 833,333 | 0.00 USD | deriv |
| 17 Sept 2025 | PURCHASE | BIODESIX INC | 15,317 | 6.04 USD | |
| 18 Sept 2025 | PURCHASE | BIODESIX INC | 3,056 | 6.17 USD | |
| 29 Aug 2025 | PURCHASE | BIODESIX INC | 3,488,372 | 0.43 USD | |
| 16 May 2025 | PURCHASE | BIODESIX INC | 4,000,000 | 0.27 USD | |
| 19 May 2025 | PURCHASE | BIODESIX INC | 723,239 | 0.34 USD | |
| 06 Mar 2025 | PURCHASE | CIPHERGEN BIOSYSTEMS INC | — | 200000.00 USD | deriv |
| 03 Dec 2024 | SALE | ACCELR8 TECHNOLOGY CORP | 200,000 | 1.57 USD | |
| 21 Nov 2024 | PURCHASE | BIODESIX INC | 100,000 | 1.23 USD | |
| 20 Nov 2024 | PURCHASE | BIODESIX INC | 200,000 | 1.17 USD | |
| 05 Nov 2024 | PURCHASE | BIODESIX INC | 100,253 | 1.36 USD | |
| 09 Jul 2024 | PURCHASE | CIPHERGEN BIOSYSTEMS INC | 6,536 | — | |
| 09 Jul 2024 | PURCHASE | CIPHERGEN BIOSYSTEMS INC | 6,536 | — | deriv |
| 28 Jun 2024 | EXERCISE | ACCELR8 TECHNOLOGY CORP | 4,737 | 0.00 USD | |
| 28 Jun 2024 | EXERCISE | ACCELR8 TECHNOLOGY CORP | 4,737 | 0.00 USD | deriv |
| 26 Jan 2024 | PURCHASE | CIPHERGEN BIOSYSTEMS INC | 28,500 | — | |
| 26 Jan 2024 | PURCHASE | CIPHERGEN BIOSYSTEMS INC | 28,500 | — | deriv |
| 29 May 2024 | EXERCISE | ACCELR8 TECHNOLOGY CORP | 7,894 | 0.00 USD | |
| 29 May 2024 | EXERCISE | ACCELR8 TECHNOLOGY CORP | 7,894 | 0.00 USD | deriv |
| 23 May 2024 | EXERCISE | BIODESIX INC | 86,960 | — |
2 purchases reported after at least 12 months of silence — most recent on 14 Aug 2013.